| A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma G Cabibbo, M Enea, M Attanasio, J Bruix, A Craxė, C Cammā Hepatology 51 (4), 1274-1283, 2010 | 314 | 2010 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology, 2011 | 304 | 2011 |
| Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease F Bortolotti, G Verucchi, C Cammā, G Cabibbo, L Zancan, G Indolfi, ... Gastroenterology 134 (7), 1900-1907, 2008 | 234* | 2008 |
| The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data F Fiorica, F Cartei, M Enea, A Licata, G Cabibbo, B Carau, A Liboni, ... Cancer treatment reviews 33 (8), 729-740, 2007 | 137 | 2007 |
| Epidemiology, risk factors and surveillance of hepatocellular carcinoma G Cabibbo, A Craxi Eur Rev Med Pharmacol Sci 14 (4), 352-355, 2010 | 116 | 2010 |
| Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study G Cabibbo, M Maida, C Genco, P Parisi, M Peralta, M Antonucci, ... World journal of hepatology 4 (9), 256, 2012 | 113* | 2012 |
| Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study C Camma, V Di Marco, A Orlando, L Sandonato, A Casaril, P Parisi, ... Journal of hepatology 42 (4), 535-540, 2005 | 113* | 2005 |
| Multimodal approaches to the treatment of hepatocellular carcinoma G Cabibbo, F Latteri, M Antonucci, A Craxė Nature Reviews Gastroenterology & Hepatology 6 (3), 159, 2009 | 94 | 2009 |
| Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C S Petta, G Cabibbo, M Enea, FS Macaluso, A Plaia, R Bruno, A Gasbarrini, ... Hepatology 59 (5), 1692-1705, 2014 | 91 | 2014 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammā, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 89 | 2016 |
| Quality of ulcer healing in gastrointestinal tract: its pathophysiology and clinical relevance T Arakawa, T Watanabe, T Tanigawa, K Tominaga, Y Fujiwara, ... World Journal of Gastroenterology: WJG 18 (35), 4811, 2012 | 89* | 2012 |
| Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems C Cammā, VD Marco, G Cabibbo, F Latteri, L Sandonato, P Parisi, ... Alimentary pharmacology & therapeutics 28 (1), 62-75, 2008 | 89 | 2008 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 88 | 2015 |
| Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension V Di Marco, V Calvaruso, D Ferraro, MG Bavetta, G Cabibbo, E Conte, ... Gastroenterology 151 (1), 130-139. e2, 2016 | 85 | 2016 |
| Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ... Journal of hepatology 64 (6), 1217-1223, 2016 | 85 | 2016 |
| Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease S Renna, C Cammā, I Modesto, G Cabibbo, D Scimeca, G Civitavecchia, ... Gastroenterology 135 (5), 1500-1509, 2008 | 82 | 2008 |
| Staging systems of hepatocellular carcinoma: a review of literature M Maida, E Orlando, C Cammā, G Cabibbo World Journal of Gastroenterology: WJG 20 (15), 4141, 2014 | 81 | 2014 |
| Direct antiviral agents and risk for HCC early recurrence: much ado about nothing C Cammā, G Cabibbo, A Craxė Journal of hepatology 65 (4), 861-862, 2016 | 80 | 2016 |
| Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma C Cammā, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ... Hepatology 57 (3), 1046-1054, 2013 | 80 | 2013 |
| Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ... Hepatology 62 (3), 784-791, 2015 | 75 | 2015 |
Calogero CammāSection of Gastroenterology, University of PalermoEmail verificata su unipa.it
